logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9802949 B1

PDFFull Text
Expired
Date of Patent:
Oct. 31, 2017

Filed:

Nov. 28, 2013

Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof

Applicant:

Sunshine Lake Pharma Co., Ltd., Dongguan, Guangdong, CN;

Inventors:

Yingjun Zhang, Dongguan, CN;

Jiancun Zhang, San Mateo, CA (US);

Hongming Xie, Dongguan, CN;

Qingyun Ren, Dongguan, CN;

Shifeng Li, Dongguan, CN;

Changping Fu, Dongguan, CN;

Bailin Hu, Dongguan, CN;

Xiwei Wu, Dongguan, CN;

Changhua Tang, Dongguan, CN;

Assignee:

SUNSHINE LAKE PHARMA CO., LTD., Dongguan, Guangdong, CN;

Attorneys:

Kam W. Law

Squire Patton Boggs (US) LLP

Primary Examiner:

Marcos Sznaidman

Int. Cl.
CPC ...
A01N 43/54 (2006.01); A61K 31/517 (2006.01); C07D 491/107 (2006.01); A61K 31/4025 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/423 (2006.01); A61K 31/427 (2006.01); A61K 31/439 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/502 (2006.01); A61K 31/5377 (2006.01); A61K 31/549 (2006.01); C07D 403/14 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 491/113 (2006.01); A61K 45/06 (2006.01); A61K 38/21 (2006.01); A61K 31/438 (2006.01); A61K 31/454 (2006.01); A61K 31/4709 (2006.01); C07D 471/08 (2006.01);
U.S. Cl.
CPC ...
C07D 491/107 (2013.01); A61K 31/4025 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/427 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/502 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 31/549 (2013.01); A61K 38/212 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/08 (2013.01); C07D 491/113 (2013.01);
Abstract

Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X', Y, Y′, A, A′, Q, Q, R-R, X, R, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.

Find Patent Forward Citations

Zhang, Yingjun. (2017). Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof (U.S. Patent No. 9802949). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9802949

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…